Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies

Irwin, David J., Cohen, Todd J., Grossman, Murray, Arnold, Steven E., Xie, Sharon X., Lee, Virginia M.-Y., Trojanowski, John Q.·2012·Brain

Cited by (282)

Items 101–200 of 282

  1. The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?
    Mark John Millan · 2014 · Dialogues in Clinical Neuroscience
  2. Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Sarah Fischer, Gail V.W. Johnson, Keith W. Nehrke · 2020 · Molecular Neurodegeneration
  3. Vitamin A Deficiency Impairs Spatial Learning and Memory: The Mechanism of Abnormal CBP-Dependent Histone Acetylation Regulated by Retinoic Acid Receptor Alpha
    Nali Hou, Lan Ren, Min Gong, Yang Bi, Yan Gu, Zhifang Dong, Youxue Liu, Jie Chen, Tingyu Li · 2014 · Molecular Neurobiology
  4. Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
    Yann Le Guen, Guo Luo, Aditya Ambati, Vincent Damotte, Iris E. Jansen, Eric Yu, Aude Nicolas, Itziar de Rojas, Thiago Peixoto Leal, Akinori Miyashita et al. · 2023 · Proceedings of the National Academy of Sciences
  5. Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis
    Liu, Qian, Wang, Xin, Hu, Yu, Zhao, Jun-Ning, Huang, Chun-Hui, Li, Ting, Zhang, Bing-Ge, He, Ye, Wu, Yan-Qing, Zhang, Zai-Jun et al. · 2023 · Redox Biology
  6. Autophagy regulation by acetylation—implications for neurodegenerative diseases
    Sung Min Son, So Jung Park, Marian Fernandez-Estévez, David Chaim Rubinsztein · 2021 · Experimental & Molecular Medicine
  7. Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation
    Todd J. Cohen, Brian H. Constance, Andrew W. Hwang, Michael James, Chao‐Xing Yuan · 2016 · PLoS ONE
  8. Molecular Mechanism of Nuclear Tau Accumulation and its Role in Protein Synthesis
    Miguel Portillo, Ekaterina Eremenko, Shai Kaluski, Alfredo García-Venzor, Lior Onn, Daniel Stein, Zeev Slobodnik, Adam Zaretsky, Uwe Ueberham, Monica Einav et al. · 2020 · Cell Reports
  9. How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
    Nirosen Vijiaratnam, Thomas Foltynie · 2023 · Brain
  10. Increased Risk of Aging-Related Neurodegenerative Disease after Traumatic Brain Injury
    Barker, Sarah, Paul, Bindu, Pieper, Andrew · 2023 · Biomedicines
  11. α‐Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
    Ildefonso Rodríguez‐Leyva, Ana Laura Calderón‐Garcidueñas, María Esther Jiménez-Capdeville, Ana Arely Rentería‐Palomo, Héctor Hernández-Rodríguez, Rodrigo Valdés‐Rodríguez, Cornelia Fuentes‐Ahumada, Bertha Torres‐Álvarez, Julio Sepúlveda‐Saavedra, Adolfo Soto‐Domínguez et al. · 2014 · Annals of Clinical and Translational Neurology
  12. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
    Yoshitaka Tamaki, Makoto Urushitani · 2022 · International Journal of Molecular Sciences
  13. Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
    Vishruti S. Makani, Bin Zhang, Heeoon Han, Yuemang Yao, Pierrik Lassalas, Kevin Lou, Ian Paterson, Virginia M.‐Y. Lee, John Q. Trojanowski, Carlo Ballatore et al. · 2016 · Acta Neuropathologica Communications
  14. Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS
    Alexandra Arenas, Jing Chen, Lisha Kuang, Kelly R. Barnett, Edward J. Kasarskis, József Gál, Haining Zhu · 2020 · Human Molecular Genetics
  15. Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer’s Disease
    Somayra S. A. Mamsa, Bruno P. Meloni · 2021 · Frontiers in Molecular Neuroscience
  16. Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
    Małgorzata Ziemka‐Nałęcz, Joanna Jaworska, Joanna Sypecka, Teresa Zalewska · 2018 · Journal of Neuropathology & Experimental Neurology
  17. Inhibition of HDAC6 Modifies Tau Inclusion Body Formation and Impairs Autophagic Clearance
    Janina Leyk, Olaf Goldbaum, Monika Noack, Christiane Richter‐Landsberg · 2014 · Journal of Molecular Neuroscience
  18. An acetylation mimicking mutation, K274Q, in tau imparts neurotoxicity by enhancing tau aggregation and inhibiting tubulin polymerization
    Jitendra Subhash Rane, Anuradha Ranjan Kumari, Dulal Panda · 2019 · Biochemical Journal
  19. Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration
    Corey T. McMillan, Jon B. Toledo, Brian Avants, Philip A. Cook, Elisabeth McCarty Wood, EunRan R. Suh, David John Irwin, John Powers, Christopher A. Olm, Lauren B. Elman et al. · 2013 · Neurobiology of Aging
  20. TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury
    Fei Gao, Mei Hu, Jian Zhang, Jack Hashem, Chu Chen · 2022 · Acta Neuropathologica
  21. Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer’s and related dementias
    Chang-ki Oh, Tomohiro Nakamura, Xu Zhang, Stuart A. Lipton · 2024 · Neuron
  22. Temporal Regulation of the Bacillus subtilis Acetylome and Evidence for a Role of MreB Acetylation in Cell Wall Growth
    Valerie J. Carabetta, Todd M. Greco, Andrew W. Tanner, Ileana M. Cristea, David A. Dubnau · 2016 · mSystems
  23. Acetylation discriminates disease-specific tau deposition
    Pijush Chakraborty, Gwladys Rivière, Alina Hebestreit, Alain Ibáñez de Opakua, Ina Maja Vorberg, Loren B. Andreas, Markus Zweckstetter · 2023 · Nature Communications
  24. Cerebral neurotoxicity of amino-modified polystyrene nanoplastics in mice and the protective effects of functional food Camellia pollen
    Hangjia Bai, Yanliang Wu, Haini Li, Yining Zhu, Ruijie Che, Fenghe Wang, Chaofeng Zhang · 2023 · The Science of The Total Environment
  25. Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β
    Tanusree Sen, Pampa Saha, Nilkantha Sen · 2018 · Science Signaling
  26. Neurodegeneration and sport
    Davis, Gavin A., Castellani, Rudolph J., McCrory, Paul · 2015 · Neurosurgery
  27. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model
    Bin Zhang, Yuemang Yao, Anne‐Sophie Cornec, Killian Oukoloff, Michael J. James, Pyry P. Koivula, John Q. Trojanowski, Amos B. Smith, Virginia M.‐Y. Lee, Carlo Ballatore et al. · 2018 · Molecular Neurodegeneration
  28. Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
    Garrett S. Gibbons, Soojung Kim, John L. Robinson, Lakshmi N. Changolkar, David John Irwin, Leslie M. J. Shaw, Virginia M.‐Y. Lee, John Q. Trojanowski · 2019 · Acta Neuropathologica Communications
  29. Effect of curcumin nanoparticles on streptozotocin-induced male Wistar rat model of Alzheimer’s disease
    Neveen A. Noor, Eman Nasr Hosny, Yasser A. Khadrawy, Iman M. Mourad, Amel Ibrahim Othman, Heba S. Aboul Ezz, Haitham S. Mohammed · 2022 · Metabolic Brain Disease
  30. Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases
    Bahareh Eftekharzadeh, Bradley T. Hyman, Susanne Wegmann · 2016 · Mechanisms of Ageing and Development
  31. Resveratrol Mitigates Hippocampal Tau Acetylation and Cognitive Deficit by Activation SIRT1 in Aged Rats following Anesthesia and Surgery
    Jing Yan, Ailin Luo, Rao Sun, Xiaole Tang, Yilin Zhao, Jie Zhang, Biyun Zhou, Hua Zheng, Honghui Yu, Shiyong Li · 2020 · Oxidative Medicine and Cellular Longevity
  32. Invited review: Drug development for tauopathies
    Fiona Grüninger · 2014 · Neuropathology and Applied Neurobiology
  33. Role of Tau Acetylation in Alzheimer’s Disease and Chronic Traumatic Encephalopathy: The Way Forward for Successful Treatment
    Lucke Wold B · 2017 · Journal of Neurology and Neurosurgery
  34. The Role of Tau Proteoforms in Health and Disease
    Zuha Waheed, Jawaria Choudhary, Faria Hasan Jatala, Fatimah, Aneeqa Noor, Inga Zerr, Saima Zafar · 2023 · Molecular Neurobiology
  35. Carbamylation promotes amyloidogenesis and induces structural changes in Tau-core hexapeptide fibrils
    V. Guru KrishnaKumar, Lokesh Baweja, Krittika Ralhan, Sharad Kumar Gupta · 2018 · Biochimica et Biophysica Acta (BBA) - General Subjects
  36. Emerging Diagnostic and Therapeutic Strategies for Tauopathies
    David G. Coughlin, David John Irwin · 2017 · Current Neurology and Neuroscience Reports
  37. Frontrunner in Translation: Progressive Supranuclear Palsy
    Ali Shoeibi, Nahid Olfati, Irene Litvan · 2019 · Frontiers in Neurology
  38. The potential role of glial cells in driving the prion-like transcellular propagation of tau in tauopathies
    Zein Amro, Andrea J. Yool, Lyndsey E. Collins‐Praino · 2021 · Brain Behavior & Immunity - Health
  39. Pseudo-acetylation of multiple sites on human Tau proteins alters Tau phosphorylation and microtubule binding, and ameliorates amyloid beta toxicity
    Marianna Karina Gorsky, Sylvie Burnouf, Oyinkan Sofola-Adesakin, Jacqueline Dols, Hrvoje Augustin, Carina Marianne Weigelt, Sebastian Grönke, Linda Partridge · 2017 · Scientific Reports
  40. Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
    Hasan A. M. M. Almansoub, Hui Ru Tang, Ying Wu, Ding‐Qi Wang, Yacoubou Abdoul Razak Mahaman, Na Wei, Yusra A. M. Almansob, Wei He, Dan Liu · 2018 · Journal of Alzheimer s Disease
  41. Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation
    Diana M. Acosta, Chiara D. Mancinelli, Clay Bracken, David Eliezer · 2021 · Journal of Biological Chemistry
  42. Tau K321/K353 pseudoacetylation within KXGS motifs regulates tau–microtubule interactions and inhibits aggregation
    Yuxing Xia, Brach M. Bell, Benoit I. Giasson · 2021 · Scientific Reports
  43. Alzheimer’s disease: phenotypic approaches using disease models and the targeting of tau protein
    Elisabetta Lauretti, Domenico Praticò · 2020 · Expert Opinion on Therapeutic Targets
  44. Myelin oligodendrocyte basic protein and prognosis in behavioral-variant frontotemporal dementia
    David John Irwin, Corey T. McMillan, EunRan R. Suh, John Powers, Katya Rascovsky, Elisabeth McCarty Wood, Jon B. Toledo, Steven Edward Arnold, Virginia M.‐Y. Lee, Vivianna M. Van Deerlin et al. · 2014 · Neurology
  45. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation
    Deepa Ajit, Hanna Trzeciakiewicz, Jui‐Heng Tseng, Connor M. Wander, Youjun Chen, Aditi Ajit, Diamond P. King, Todd J. Cohen · 2019 · Journal of Biological Chemistry
  46. Therapeutic Strategies for Restoring Tau Homeostasis
    Zapporah T. Young, Sue‐Ann Mok, Jason E. Gestwicki · 2017 · Cold Spring Harbor Perspectives in Medicine
  47. Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies
    Hai Yang, Jin‐Ping Li, Xiaoxiong Li, Linqiu Ma, Mingliang Hou, Huadong Zhou, Rui Zhou · 2022 · Frontiers in Molecular Neuroscience
  48. Pathological features of preclinical or early clinical stages of corticobasal degeneration: a comparison with advanced cases
    Naoki Nishida, Koji Yoshida, Yukiko Hata, Yuichi Arai, Koshi Kinoshita · 2015 · Neuropathology and Applied Neurobiology
  49. Modulatory effect of methylsulfonylmethane against BPA/γ-radiation induced neurodegenerative alterations in rats: Influence of TREM-2/DAP-12/Syk pathway
    Mohamed Khairy Abdel-Rafei, Noura Magdy Thabet · 2020 · Life Sciences
  50. Brain insulin resistance linked Alzheimer’s and Parkinson’s disease pathology: An undying implication of epigenetic and autophagy modulation
    Violina Kakoty, K C Sarathlal, Shobha Kumari, Chih‐Hao Yang, Sunil Kumar Dubey, Amirhossein Sahebkar, Prashant Kesharwani, Rajeev Taliyan · 2023 · Inflammopharmacology
  51. Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of neuroprotection and neurodegeneration
    Christiane Richter‐Landsberg · 2015 · Biological Chemistry
  52. Cellular polyamines condense hyperphosphorylated Tau, triggering Alzheimer’s disease
    Stefan M. Ivanov, Mariyana Atanasova, Ivan Dimitrov, Irini Atanas Doytchinova · 2020 · Scientific Reports
  53. Advances in Genetics and Epigenetic Alterations in Alzheimer’s Disease: A Notion for Therapeutic Treatment
    Rubén Rabaneda‐Bueno, Beatriz Mena‐Montes, Sara Torres‐Castro, Norma Torres‐Carrillo, Nora Magdalena Torres-Carrillo · 2021 · Genes
  54. Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer’s disease
    Sanaz Arezoumandan, Sharon Xiangwen Xie, Katheryn A Q Cousins, Dawn J. Mechanic-Hamilton, Claire S. Peterson, Camille Y. Huang, Daniel T. Ohm, Ranjit Ittyerah, Corey T. McMillan, David A. Wolk et al. · 2022 · Acta Neuropathologica
  55. Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases
    Lan Zhang, Yi Liu, Yingying Lu, Guan Wang · 2022 · Biochemical Pharmacology
  56. Astrocyte adaptation in Alzheimer’s disease: a focus on astrocytic P2X7R
    Paula Beltran-Lobo, Matthew J. Reid, María Jiménez-Sánchez, Alexei Verkhratsky, Beatriz Gomez Perez‐Nievas, Wendy J. Noble · 2022 · Essays in Biochemistry
  57. The Acetyl Mimicking Mutation, K274Q in Tau, Enhances the Metal Binding Affinity of Tau and Reduces the Ability of Tau to Protect DNA
    Jitendra Subhash Rane, Anuradha Ranjan Kumari, Dulal Panda · 2019 · ACS Chemical Neuroscience
  58. A Distinct Tau Code Controlled by HDAC6 is Linked to Tau Pathogenesis and the Neuronal Stress Response
    Jui‐Heng Tseng, Aditi Ajit, Zarin Tabassum, Niyati Patel, Xu Tian, Youjun Chen, Alex W. Prevatte, Karen Ling, Frank Rigo, Rick B. Meeker et al. · 2020 · Cell Reports
  59. Sirtuin Oxidative Post-translational Modifications
    Kelsey Kalous, Sarah L. Wynia‐Smith, Brian C. Smith · 2021 · Frontiers in Physiology
  60. KIBRA repairs synaptic plasticity and promotes resilience to tauopathy-related memory loss
    Grant Kauwe, Kristeen A. Pareja-Navarro, Lei Yao, Jackson H. Chen, Ivy Wong, Rowan Saloner, Helen Cifuentes, Alissa L. Nana, Samah Shah, Yaqiao Li et al. · 2024 · Journal of Clinical Investigation
  61. Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280–acetylated tau in cell and mouse models
    Song, Ha-Lim, Kim, Na-Young, Park, Jaewan, Kim, Meong Il, Jeon, Yu-Na, Lee, Se-Jong, Cho, Kwangmin, Shim, Young-Lim, Lee, Kyoung-Hye, Mun, Yeon-Seon et al. · 2023 · Journal of Clinical Investigation
  62. Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry
    Michael J. Ellis, Christiana Lekka, Katie L. Holden, Hanna Tulmin, Faheem Seedat, Darragh Patrick O'Brien, Shalinee Dhayal, Marie‐Louise Zeissler, Jakob Grunnet Knudsen, Benedikt Mathias Kessler et al. · 2024 · Acta Neuropathologica
  63. Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
    Lorena Sordo, Alessandra Cadete Martini, E. Fiona Houston, Elizabeth Head, Danièlle Audry Gunn-Moore · 2021 · Frontiers in Aging
  64. The Structure Biology of Tau and Clue for Aggregation Inhibitor Design
    Dan Wang, Xianlong Huang, Lu Yan, Luo‐Qi Zhou, Yan Chang, Jinhu Wu, Zhengding Su, Yongqi Huang · 2021 · The Protein Journal
  65. Disease-associated patterns of acetylation stabilize tau fibril formation
    Li, Li, Nguyen, Binh A., Mullapudi, Vishruth, Li, Yang, Saelices, Lorena, Joachimiak, Lukasz A. · 2023 · Structure
  66. Inhibition of Early Upstream Events in Prodromal Alzheimer’s Disease by Use of Targeted Antioxidants
    Kedar Nath Prasad, Stephen Claude Bondy · 2014 · Current Aging Science
  67. Tau Monoclonal Antibody Generation Based on Humanized Yeast Models
    Joëlle Rosseels, Jeff Van den Brande, Marie Violet, Dirk Jacobs, Pierre Grognet, Juan M. Lopez, Isabelle Huvent, Marina Caldara, Erwin Swinnen, Anthony Papegaey et al. · 2014 · Journal of Biological Chemistry
  68. Polyamine Dysregulation and Nucleolar Disruption in Alzheimer’s Disease
    Wesley H. Brooks · 2024 · Journal of Alzheimer s Disease
  69. Sexual Dimorphism in Neurodegenerative Diseases and in Brain Ischemia
    Teresa Zalewska, Paulina Pawelec, Karolina Ziąbska, Małgorzata Ziemka‐Nałęcz · 2022 · Biomolecules
  70. Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau
    Hyeanjeong Jeong, Seulgi Shin, Jun‐Seok Lee, Soo Hyun Lee, Ja‐Hyun Baik, Sungsu Lim, Yun Kyung Kim · 2019 · International Journal of Molecular Sciences
  71. Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction
    Giacomo Siano, Chiara Falcicchia, Nicola Origlia, Antonino Cattaneo, Cristina Di Primio · 2021 · International Journal of Molecular Sciences
  72. The human brain acetylome reveals that decreased acetylation of mitochondrial proteins associates with Alzheimer's disease
    Lidan Sun, Ruchika P. Bhawal, Hui Xu, Huan‐Lian Chen, Elizabeth T. Anderson, V Haroutunian, Abigail C. Cross, Sheng Zhang, Gary E. Gibson · 2021 · Journal of Neurochemistry
  73. Tau acetylation at K280 regulates tau phosphorylation
    Min-Seok Kim, Yeon‐Seon Mun, Seung‐Eun Lee, Woo-Young Cho, Seung-Hwan Han, Dong‐Hou Kim, Seung‐Yong Yoon · 2022 · International Journal of Neuroscience
  74. Unraveling the Influence of K280 Acetylation on the Conformational Features of Tau Core Fragment: A Molecular Dynamics Simulation Study
    Yu Feng Zou, Lulu Guan · 2021 · Frontiers in Molecular Biosciences
  75. Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members
    Andrew W. Hwang, Hanna Trzeciakiewicz, Dave Friedmann, Chao‐Xing Yuan, Ronen Marmorstein, Virginia M.‐Y. Lee, Todd J. Cohen · 2016 · PLoS ONE
  76. Astrocytes Derived from Familial and Sporadic Alzheimer’s Disease iPSCs Show Altered Calcium Signaling and Respond Differently to Misfolded Protein Tau
    Veronika Brezováková, Eva Syková, Santosh Jadhav · 2022 · Cells
  77. Acetylation and phosphorylation processes modulate Tau’s binding to microtubules: A molecular dynamics study
    Tarsila G. Castro, Tiago Ferreira, Teresa Matamá, Florentina‐Daniela Munteanu, Artur Manuel Cavaco-Paulo · 2022 · Biochimica et Biophysica Acta (BBA) - General Subjects
  78. Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy
    Yi Liu, Ming Tan, Meng‐Shan Tan · 2023 · Molecular and Cellular Biochemistry
  79. Molecular features of human pathological tau distinguish tauopathy-associated dementias
    Mukesh Kumar, Christoph N. Schlaffner, Shaojun Tang, Maaike A. Beuvink, Arthur Viodé, Waltraud Mair, Meenakshi Jha, Ceren Uncu, Hendrik Wesseling, Tian Wang et al. · 2026 · Cell
  80. Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis
    Yufeng Ding, Honggang Chi, Jialiang Shao, Tiezhu Shi, Hua Tao Yu, Xiang Wang, Xiongjun Wang · 2022 · Clinical and Translational Medicine
  81. Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer’s Disease Brain
    Stefani N. Thomas, Austin J. Yang · 2016 · Methods in molecular biology
  82. Hemimegalencephaly and tuberous sclerosis complex: A rare yet challenging association
    Christina Sidira, Efthymia Vargiami, Pinelopi Dragoumi, Dimitrios Zafeiriou · 2020 · European Journal of Paediatric Neurology
  83. Drugs repurposing in the experimental models of Alzheimer’s disease
    Sheer A. Joodi, Weam W. Ibrahim, Mahmoud Mohamed Khattab · 2025 · Inflammopharmacology
  84. Palmitic Acid Induces Posttranslational Modifications of Tau Protein in Alzheimer’s Disease–Related Epitopes and Increases Intraneuronal Tau Levels
    Valeria Melissa García-Cruz, Clorinda Arias · 2024 · Molecular Neurobiology
  85. Hiding in plain sight: Complex interaction patterns between Tau and 14-3-3ζ protein variants
    Radek Crha, Aneta Kozeleková, Alena Hofrová, Lucia Iľkovičová, Norbert Gašparik, Pavel Kadeřávek, Jozef Hritz · 2024 · International Journal of Biological Macromolecules
  86. Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review
    Elise E. Dunning, Boris Decourt, Nasser H. Zawia, Holly A. Shill, Marwan Noel Sabbagh · 2024 · Neurology and Therapy
  87. The tau of PSP: A long road to treatment
    Lawrence I. Golbe · 2014 · Movement Disorders
  88. The Brain Protein Acylation System Responds to Seizures in the Rat Model of PTZ-Induced Epilepsy
    Lev G. Zavileyskiy, Vasily A. Aleshin, Thilo Kaehne, Irina S. Karlina, Artem V. Artiukhov, Maria V. Maslova, Anastasia V. Graf, Victoria I. Bunik · 2022 · International Journal of Molecular Sciences
  89. A small‐molecule microtubule‐stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's disease
    Yuemang Yao, Megan Muench, Thibault Alle, Bin Zhang, Bobby Lucero, Roxanne Perez‐Tremble, Dominic McGrosso, Mira Newman, David J. Gonzalez, Virginia M.‐Y. Lee et al. · 2024 · Alzheimer s & Dementia
  90. Acetylation of lysine residues in apomyoglobin: Structural changes, amyloid fibrillation, and role of surface charge
    Mehrnaz Azami-Movahed, Ali Akbar Meratan, Atiyeh Ghasemi, Azadeh Ebrahim‐Habibi, Mohsen Nemat‐Gorgani · 2017 · International Journal of Biological Macromolecules
  91. Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation against the Aggregation of Human Tau Fragment PHF6
    Yu Feng Zou, Lulu Guan, Jingwang Tan, Bote Qi, Ying Wang, Qingwen Zhang, Yunxiang Sun · 2023 · The Journal of Physical Chemistry B
  92. Progress in the treatment of Parkinson-Plus syndromes
    Nahid Olfati, Ali Shoeibi, Irene Litvan · 2018 · Parkinsonism & Related Disorders
  93. RETRACTED ARTICLE: Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
    Mennatallah O. Zaki, S. El-Desouky, Doaa A. Elsherbiny, Mohamed Salama, Samar S. Azab · 2022 · Inflammopharmacology · Retracted
  94. Tau Protein: Function and Pathology
    Hanna Rosenmann, David L Blum, Rakez Kayed, Lars Matthias Ittner · 2012 · International Journal of Alzheimer s Disease
  95. Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells
    Jun‐Fei Zhang, Zhi‐Ting Fang, Jun‐Ning Zhao, Gong‐Ping Liu, Xin Shen, Gaofeng Jiang, Qian Rong Liu · 2024 · Journal of Neurochemistry
  96. Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer’s disease in rats: role of AMPK/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress
    Ebtsam S Abdel-Lah, Hoda S. Sherkawy, Wafaa H. Mohamed, Mariam A. Fawy, Asmaa A. Hasan, Asmaa A. Muhammed, Amira F. Taha, Abeer A. Tony, Nashwa Hamad, Marwa G. Gamea · 2025 · Inflammopharmacology
  97. Quantitative Acetylomics Reveals Dynamics of Protein Lysine Acetylation in Mouse Livers During Aging and Upon the Treatment of Nicotinamide Mononucleotide
    Jingshu Li, Ye Cao, Kongyan Niu, Jiaqian Qiu, Han Wang, Yingnan You, Dean Li, Yu Luo, Zheng‐Jiang Zhu, Yaoyang Zhang et al. · 2022 · Molecular & Cellular Proteomics
  98. A micronutrient mixture with collagen peptides, probiotics, cannabidiol, and diet may reduce aging, and development and progression of age-related alzheimer’s disease, and improve its treatment
    Kedar Nath Prasad · 2022 · Mechanisms of Ageing and Development
  99. Development of tau-directed Small Molecule Modulators for Alzheimer’s Disease: a Recent Patent Review (2014–2018)
    Ha E Lee, Dami Lim, Jae Yeol Lee, Sang Min Lim, Ae Nim Pae · 2019 · Pharmaceutical Patent Analyst
  100. Ceramide: a central regulator in Alzheimer’s disease pathogenesis
    Priyanka Choudhary, Shilpa Kumari, Kajal Bagri, Rahul R Deshmukh · 2025 · Inflammopharmacology